PALI short interest
Palisade Bio Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 31,015,282 |
|---|---|
| Change vs prior report | 747,996 (+2.5%) |
| Change over six months | +20.4% |
| Days to cover | 6.06 (sector: 3.78) |
| Average daily volume | 5,116,812 |
| Rank in Healthcare | #314 of 922 by days to cover |
PALI short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 31,015,282 | +2.5% | 6.06 | 5,116,812 |
| 2026-09-15 | 30,267,286 | -2.0% | 13.76 | 2,200,098 |
| 2026-08-31 | 30,902,111 | -7.5% | 19.11 | 1,616,674 |
| 2026-08-14 | 33,391,318 | -0.9% | 22.04 | 1,515,332 |
| 2026-07-31 | 33,699,995 | -9.0% | 14.58 | 2,311,213 |
| 2026-07-15 | 37,022,896 | +15.2% | 9.98 | 3,711,036 |
| 2026-06-30 | 32,129,387 | +1.9% | 5.35 | 6,010,460 |
| 2026-06-15 | 31,519,540 | +2.3% | 11.89 | 2,649,988 |
| 2026-05-29 | 30,806,978 | +14.4% | 10.79 | 2,856,005 |
| 2026-05-15 | 26,920,839 | +3.0% | 10.41 | 2,587,250 |
| 2026-04-30 | 26,147,446 | +2.0% | 5.21 | 5,014,099 |
| 2026-04-15 | 25,639,730 | -0.5% | 6.97 | 3,679,834 |
| 2026-03-31 | 25,770,313 | -1.5% | 5.43 | 4,747,574 |
| 2026-03-13 | 26,152,010 | -2.2% | 8.79 | 2,974,474 |
| 2026-02-27 | 26,733,844 | +5.5% | 8.83 | 3,026,918 |
| 2026-02-13 | 25,352,984 | +20.2% | 8.00 | 3,167,745 |
| 2026-01-30 | 21,095,322 | +20.6% | 3.50 | 6,025,264 |
| 2026-01-15 | 17,496,604 | +9.7% | 3.02 | 5,795,338 |
| 2025-12-31 | 15,949,282 | +24.4% | 2.83 | 5,642,145 |
| 2025-12-15 | 12,819,308 | -8.3% | 2.24 | 5,721,615 |
| 2025-11-28 | 13,976,371 | +75.9% | 3.80 | 3,679,114 |
| 2025-11-14 | 7,946,168 | +4.6% | 2.15 | 3,690,248 |
| 2025-10-31 | 7,594,147 | +28.3% | 1.53 | 4,949,544 |
| 2025-10-15 | 5,920,702 | +470.5% | 1.00 | 30,751,163 |
| 2025-09-30 | 1,037,875 | +108.7% | 1.00 | 1,676,437 |
import finzdata as yf
yf.Ticker("PALI").short_interest # every report since 2017
yf.Client().short_interest(["PALI"], start="2018-01-01")Healthcare short interest · PALI price history · Who owns PALI · All short interest